Atlas Trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

Clinical trial NCT03001115 · COMPLETED

Trial details

NCT number
NCT03001115
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Hidradenitis Suppurativa (HS)
Start date
2017-03-10
Primary completion
2019-07-31
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.